Wei Zheng

Wei Zheng

Auto-generated profile, based on publicly available information

Wei Zheng

From the Departments of Ultrasound (L.X., J.Z., H.Z., G.W., W.Z., X.P., L.L.) and Head and Neck Surgery (A.Y.), Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, PR China; and Department of Ultrasound, Sun Yat-sen University, Affiliated Hospital 8, Shenzhen, PR China (W.T., Y.L.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Radiology
Verified
Journal Article
Open access
WZWei Zheng
Wei Zheng
QLQing Li
Qing Li
XZXue-Bin Zou
Xue-Bin Zou
JWJian-Wei Wang
Jian-Wei Wang
FHFeng Han
Feng Han
JZJianhua Zhou
Jianhua Zhou
The contrast-enhanced US Liver Imaging Reporting and Data System version 2017 diagnostic algorithm is effective in predicting hepatocellular carcinoma, although diagnostic performance may be improv... Background Use of contrast material–enhanced (CE) US Liver Imaging Reporting and Data System (LI-RADS) version 2017 has not been validated in large populations where hepatitis B virus (HBV) is ende...

1 August 2023 in Radiology
Verified
Journal Article
Closed access
LLLingling Li
Lingling Li
XZXuebin Zou
Xuebin Zou
WZWei Zheng
Wei Zheng
YLYu Li
Yu Li
XXXiaohong Xu
Xiaohong Xu
JZJianhua Zhou
Jianhua Zhou
Background Liver Imaging Reporting and Data System (LI-RADS) was designed for contrast-enhanced US (CEUS) with pure blood pool agents to diagnose hepatocellularfcarcinoma (HCC), such as sulfur hexafluoride (SHF), but Kupffer-cell agents, such as perfluorobutane (PFB), allow additional lesion characterization in the Kupffer phase yet remain unaddressed. Purpose To compare the diagnostic performance of three algorithms for HCC diagnosis: two algorithms based on CEUS LI-RADS version 2017 for both SHF and PFB and a modified algorithm incorporating Kupffer-phase findings for PFB. Materials and Methods This multicenter prospective study enrolled high-risk patients for HCC from June 2021 to December 2021. Each participant underwent same-day SHF-enhanced US followed by PFB-enhanced US. Each liver observation was assigned three LI-RADS categories according to each algorithm: LI-RADS SHF, LI-RADS PFB, and modified PFB. For modified PFB, observations at least 10 mm with nonrim arterial phase hyperenhancement were upgraded LR-4 to LR-5 if there was no washout with a Kupffer defect and were reassigned LR-M to LR-5 if there was early washout with mild Kupffer defect. The reference standard was pathologic confirmation or composite (typical CT or MRI features, or 1-year size stability and/or reduction). Diagnostic metrics of LR-5 for HCC using the three algorithms were calculated and compared using the McNemar test. Results Overall, 375 patients (mean age, 56 years ± 11 [SD]; 318 male patients, 57 female patients) with 424 observations (345 HCCs, 40 non-HCC malignancies, 39 benign lesions) were enrolled. PFB and SHF both using LI-RADS showed no significant difference in sensitivity (60% vs 58%; P = .41) and specificity (96% vs 95%; P > .99). The modified algorithm with PFB had increased sensitivity (80% vs 58%; P < .001) and a nonsignificant decrease in specificity (92% vs 95%; P = .73) compared with LI-RADS SHF. Conclusion Based on CEUS LI-RADS version 2017, both SHF and PFB achieved high specificity and relatively low sensitivity for HCC diagnosis. When incorporating Kupffer-phase findings, PFB had higher sensitivity without loss of specificity. Chinese Clinical Trial Registry no. ChiCTR2100047035 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Kim in this issue.

1 May 2023 in Radiology
Verified
Journal Article
Closed access
LXLingli Xiao
Lingli Xiao
JZJianhua Zhou
Jianhua Zhou
WTWen Tan
Wen Tan
YLYing Liu
Ying Liu
HZHaoming Zheng
Haoming Zheng
LLLongzhong Liu
Longzhong Liu